New technology and life sciences partner joins the firm, announces Torys

July 13, 2004

TORONTO, July 13, 2004—Cheryl V. Reicin, a leading U.S. attorney in the technology and life sciences arena, has joined Torys LLP as practice leader of the Technology and Life Sciences Group.

"Cheryl Reicin brings a distinguished reputation in U.S. corporate securities, technology law and life sciences to our cross-border law practice,L says Les Viner, Torys’ managing partner.

"Technology and life science companies have no borders and look to raise capital and market their products around the world. Cheryl is plugged into this process and will be working with clients in Toronto, the United States and internationally."

Ms. Reicin joins Torys from McDermott, Will & Emery in New York, where she chaired the 85-attorney Life Sciences Group. Her corporate and securities practice focuses on biotechnology, medical devices, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centres and universities.

Ms. Reicin counsels companies from inception through all stages of their growth cycle. As her clients grow, she assists them in formulating domestic and international growth strategies and in sourcing capital.

Ms. Reicin’s advisory experience spans the wide range of issues that biotech and technology companies typically face, including venture and later stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She has developed a client-focused practice in which she coordinates the domestic and international structuring, intellectual property planning and regulatory strategy for her clients.

Ms. Reicin graduated summa cum laude from Barnard College and is a 1984 graduate of Harvard Law School. She is a member of the New York and Massachusetts bars. She is also active in several charitable and civic organizations.

Ms. Reicin currently serves as an advisory board member of Hadassit, the technology transfer arm of Hadassah Medical Center in New York. She is a Business Advisory Board member of the Institute for the Study of Aging, Inc. in New York, and a director of the Entrepreneurship Institute in New York. She is the author of numerous publications, including An Insider's Guide to Going Public.


Press Contact